Upcoming Medical Conferences in Boston

Limb Lengthening and Reconstruction Society (LLRS) 28th Annual Scientific Meeting is organized by Limb Lengthening and Reconstruction Society (LLRS) and will be held from July 19 - 20, 2019 at Fairmont Copley Plaza, Boston, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.

52nd Association of Pathology Chairs (APC) 2019 Annual Meeting is organized by Association of Pathology Chairs (APC) and will be held from Jul 21 - 24, 2019 at Seaport Hotel, Boston, Massachusetts, United States of America. The target audience for this medical event is professionals (MD, DO, PhD) and others who serve as the academic, medical, scientific, and administrative leaders of departments of pathology and laboratory medicine in the United States and Canada. The APC Annual Meeting is a three-day meeting that provides educational activities for three major target audiences: • Chairs of academic departments of pathology and laboratory medicine. • Program directors and associate directors of pathology residency training programs. • Medical student educators of pathology in accredited medical schools. • Faculty members aspiring to these positions. The objective of the meeting is to facilitate knowledge acquisition regarding the ability of academic Pathology and Laboratory Medicine departments to carry out their missions in teaching, clinical service, and research. The meeting therefore focuses on undergraduate (medical school) and graduate (residency and fellowship) Pathology education, and the practice of Pathology and Laboratory medicine in academic medical centers and hospitals. Content focuses on issues such as the development of educational programs and curricula for the training of medical students, residents, fellows, and senior pathologists on providing cost-effective, high-quality clinical service to patients. The meeting also features content related to research and implementation of cutting edge practice tools, such as diagnostics, genomic medicine, and bioinformatics; and their implications on future healthcare delivery, as well as workforce development and realignment to support current and new skill sets required to practice Pathology and Laboratory Medicine now and into the future. Theme: Innovation Through Collective Excellence: Shaping the Future of Pathology. Additional details will be posted as soon as they are available.​

42nd Annual Intensive Review of Internal Medicine is organized by Harvard Medical School (HMS), The Penzias Group and will be held from Jul 21 - 28, 2019 at Renaissance Boston Waterfront Hotel, Boston, Massachusetts, United States of America. Who Should Attend • Physicians, NPs, PAs seeking a comprehensive update of the state-of-the-art in Internal Medicine • Physicians preparing to certify/recertify Earn up to • 97.75 AMA PRA Category 1 Credits™ • 97.75 ABIM MOC points • 94.25 AAFP Prescribed credits Course Description: With more than 120 interactive lectures, case discussions, and board preparation sessions, this CME program is the most comprehensive review of internal medicine offered by the clinical faculty of Harvard Medical School. It offers accelerated learning: ► For clinicians seeking a practical and comprehensive review that ensures they are up to date across all major fields of internal medicine: • Newer options for diagnosis: what to choose, when, and why • Treatment and care management strategies to optimize patient outcomes • How to avoid medical mistakes • Improved approaches to common and complex clinical challenges • Navigating screening controversies ► For physicians preparing to certify or recertify and are seeking a thorough, proven preparatory course in advance of their taking the ABIM board examination: • Daily board review questions • Sessions to guide efficient preparation and study • Exam practice sessions with an audience response system that provides immediate feedback • 2,000-page syllabus and home study guide • Test-taking strategies and skills development • A copy of the 3rd edition of The Brigham Intensive Review of Internal Medicine Sessions and board preparation span all major fields of internal medicine and are led by Harvard Medical School’s most distinguished clinical faculty in the fields of: • Cardiovascular Medicine • Oncology • Neurology • Critical Care • Nephrology • Hematology • Gastroenterology • Infectious Diseases • Pulmonary Diseases • Women's Health • Rheumatology • Endocrinology • Allergy and Immunology • Hospital Medicine • Dermatology • Biostatistics • General Internal Medicine

1st Microbiome Movement - Oncology Response Summit is organized by Hanson Wade and will be held from Jul 22 - 24, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America. Description: The inaugural Microbiome Movement – Oncology Response Summit has been established to improve your understanding on how to translate microbiome-oncology research from discovery settings and from retrospective clinical investigations into the routine oncology practice. This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from pre-clinical, translational and clinical scientists from large pharma, biotech and academia presenting the latest case studies and in-depth discussion on key topics including: • Discover the mechanistic pathways underpinning the causality of the microbiome in cancer and consequential effects of cancer therapeutics on microbial dysbiosis • Understand how - omics data are being integrated to inform cancer clinical decision making • Investigate translational applications of the microbiome in cancer 1) to improve clinical safety outcomes, 2) as a validated biomarker to predict patient response and 3) as an LBP monotherapy or adjuvant to enhance therapeutic efficacy (particularly in the context of immunotherapy) • Explore the nutritional interventions for cancer treatment and prevention • Harness clinical experience to establish gold standards for cancer clinical trials incorporating the microbiome as a measurable endpoint • Uncover how to integrate the microbiome into existing oncology medical practice and drug development infrastructures There is no question that applying the microbiome in cancer is the next frontier to enhance already existing oncology pipelines. Join us to advance the next wave of robust and evidence-based microbiome research into routine oncology practice. Pre-Conference Workshop: Jul 22, Mon, 13:00 – 16:00​​ Reading Signals from the Noise: Working Smartly with –Omics to Inform Clinical Decision Making Artists / Speakers: Gregory Poore,  MD/PhD Candidate,  UCSD Centre for Microbiome Innovation, Wendy Garrett,  Professor of Immunology & Infectious Diseases,  Harvard T.H. Chan School of Public Health, Fyza Shaikh,, MD  Postdoctoral Fellow John Hopkins Hospital, Alex Stevenson,  Chief Scientific Officer,  4D Pharma, James Burgess,  VP Innovation,  Finch Therapeutics, Sergei Grivennikov,  Assistant Professor,  Fox Chase Cancer Center, Imke Mulder,  Director of Research,  4D Pharma, Maya Kahan-Hanum,  CRC Project Leader,  BiomX, Romain Daillère,  Head of Preclinical Research & Co- Founder,  EverImmune, Bruce Roberts,  Chief Scientific Officer,  Vedanta Biosciences, Lata Jayaraman,  Head of Tumor Immunotherapy,  Seres Therapeutics, Daniel van der Lelie,  Chief Scientific Officer,  Gusto Global, Mingyang Song, MD,  Assistant Professor,  Massachusetts General Hospital and Harvard Medical School, Marcel van den Brink, MD,  Head of Hematologic Oncology,  Memorial Sloan Kettering Cancer Center, Xue Liang,  Senior Scientist, Microbiome/ Molecular Discovery,  Merck Exploratory Science Center, Sandrine Miller- Montgomery,  Executive Director, Center for Microbiome Innovation - Professor of Practice, Bioengineering,  UCSD Centre for Microbiome Innovation, Diwakar Davar, MD,  Assistant Professor of Medicine,  University of Pittsburgh, Jennifer McQuade, MD,  Assistant Professor,  MD Anderson Cancer Center, Trevor Lawley,  Chief Scientific Officer & Co- Founder,  Microbiotica, Christophe Bonny,  Chief Scientific Officer,  Enterome Biosciences.

Radiological Emergency Planning: Terrorism, Security, and Communication is organized by Harvard T.H. Chan School of Public Health Executive and Continuing Professional Education (ECPE) and will be held from Jul 22 – 26, 2019 at Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America. Who Should Participate: This course is designed for anyone involved in emergency planning, response, or recovery in the public, private, or nonprofit sectors. Health physicists, public safety professionals, and first receivers and responders will also find this program beneficial. Foreign and domestic participants from organizations with the following functions are likely to attend: • Nuclear or energy-industry regulatory bodies • Homeland security and emergency management agencies • Defense or military organizations • Departments of health • Power generation, especially nuclear power generation • State and local emergency agencies • State radiation control agencies. Course Description: Radiological emergency planning is used to mitigate the effects of events such as a release at a nuclear power plant, the detonation of an improvised nuclear device, or an explosion involving a radiological dispersal device (dirty bomb). While these types of emergencies are rare, they have the potential for devastating and widespread harm. Minimizing the likelihood of harm to the public requires a thorough and well-designed radiological emergency plan. Radiological Emergency Planning: Terrorism, Security, and Communication brings together leaders in radiation protection and emergency management to provide you with skills and strategies to effectively plan for radiological emergencies. As a participant, you will learn to prepare for, respond to, and mitigate the effects of radiological emergencies at the federal, state, local, or individual facility level. This program is unique in bringing together stakeholders from across agencies, functions, and backgrounds for an intensive look at effective planning for emergencies involving radioactive materials. • Emergency preparedness for terrorist activities • Lessons learned about how best to communicate with the media and public • Terrorist incidents involving radioactive materials • The new US federal framework for Homeland Security • Updates on emergency preparedness issues for nuclear utilities Learning Objectives: • Apply basic principles and fulfill requirements for a comprehensive radiation emergency plan • Demonstrate compliance with roles and responsibilities that support Department of Homeland Security initiatives • Deploy decision-making to assist in state and local reaction planning for radiological emergencies • Integrate lessons learned about communications into specific emergency response plans • Understand the need for, and application of, protective action guides in emergency planning • Medically manage the casualties of radiological incidents without significantly increasing risks to first responders and first receivers. Additional details will be posted as soon as they are available.

Comprehensive Instructor Workshop is organized by Center for Medical Simulation (CMS) and will be held from Jul 22 - 26, 2019 at Center for Medical Simulation (CMS), Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 40.5 AMA PRA Category 1 Credits™. Description: This intensive immersion in healthcare simulation is led by some of the world’s leading simulation educators. Integrating theories from multiple disciplines, the course focuses on simulation design and debriefing using the Debriefing With Good Judgment© method. Topics also include assessment in simulation and making an impact with simulation in your organization. Attendees join a growing community of Center for Medical Simulation graduates who are positioned as leaders in the field. Daily formats vary and include simulation scenarios, lectures, small and large group discussions, case studies, and practical exercises with feedback. The course combines didactic and experiential learning with practice and feedback. Participants will run and debrief simulation cases and receive coaching and feedback on debriefing skills from leading debriefing experts. Course Topics Include: • Creating a challenging and safe learning environment • Teaching clinical thinking and teamwork skills • Developing debriefing skills • Creating, conducting, and debriefing realistic simulation scenarios • Avoiding simulation pitfalls and ineffective debriefing techniques • Advancing simulation within one’s institution Additional details will be posted as soon as they are available.

2nd Annual Neuropsychiatric Drug Development (NPD) Summit is organized by Hanson Wade and will be held from Jul 23 - 25, 2019 at Wyndham Boston Beacon Hill, Boston, Massachusetts, United States of America. Description: With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential. Historically, drug development within neuropsychiatry has been stifled for decades by a lack of scientific progress in the neuropsychiatric field combined with costly and challenging clinical trials. The abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the NPD summit, as well as unravelling the complexities of developing truly transformative neuropsychiatric drugs. With 70+ of the field’s thought-leaders uniting from around the world, NPD summit will be your opportunity to not only gather the latest scientific insights but to discuss, in depth, the challenges that have been stifling the progress of neuropsychiatric drug development such as translatable models, biomarkers and looking to target neuropsychiatry symptomatically. Book early to avoid disappointment. About the Event: Built with thought-leaders at Sage Therapeutics, Janssen and Lundbeck the 2nd Annual NPD meeting will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. Dedicated to overcoming challenges in neuropsychiatric drug development, this comprehensive discussion and networking forum will cover: • Reviewing the current clinical landscape to share learned lessons, predict potential success and identify future opportunities • Determine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy • Utilize what we know from the clinical to improve our use of translational strategies • Discuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals • Review symptomatic focused drug development to identify the benefits and impact future regulation • Evaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology • Improving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders Pre-Conference Workshops Workshop A: Tuesday July 23, 8:00am – 11:00am Understanding the Role of Genetics in Neuropsychiatric Disorders Workshop B: Tuesday July 23, 11:30am – 2:30pm Reviewing the Potential for Precision Medicine in Neurological Diseases Workshop C: Tuesday July 23, 3:00pm – 6:00pm Mitigating Risk in CNS Clinical Trials Speakers: Al Robichaud, Chief Scientific Officer, Sage Therapeutics, Andreas Meier, Senior Medical Director, Ophthalmology, Pain and New Indications, Biogen, Alan Schatzberg, Professor, Psychiatry and Behavioral Sciences, Stanford University, Bruce Kimmel, Chief Executive Officer, Vidrio Technologies, Christopher Missling, Chief Executive Officer, Anavex Life Sciences, Daniel Hoeppner, Associate Director, Astellas, Elise Robinson, Assistant Professor, Harvard University, Eric Schaeffer, Senior Director, Neuroscience Innovation, Johnson andJohnson, George Papakostas, Scientific Director, Massachusetts General Hospital, Gopi Shanker, Director, Head of Psychiatry, Novartis, James Cassella, Chief Development Officer, Concert Pharmaceuticals , Jason Uslaner, Executive Director, Neuroscience, Merck, Joris Van Dam, Executive Director, Head of Digital Therapeutics, Novartis, Kevin Sanders, Global Development Lead Autism, Roche, Laura Corradini, Deputy Global Head Business Development and Licensing, CNS, Boehringer Ingelheim, Sean Smith, Executive Director, Neuroscience Discovery, Merck, Seth Hopkins, Executive Director, Translational Medicine, Sunovion, Shil Patel, Vice President, Codiak BioSciences, Stevin Zorn, President and CEO, MindImmune Therapeutics Inc, Sylvain Celanire, Chief Executive Officer, PRAGMA Therapeutics Time: 8:00 am - 4:30 pm

Society for Developmental Biology (SDB) 78th Annual Meeting is organized by Society for Developmental Biology (SDB) and will be held from Jul 25 - 29, 2019 at Boston Marriott Copley Place, Boston, Massachusetts, United States of America.​ Additional details will be posted as soon as they are available.

Botulinum Toxins & Dermal Fillers & Frontline TMJ & Orofacial Pain is organized by American Academy of Facial Esthetics (AAFE) and will be held from Jul 26 - 27, 2019 at Boston, Massachusetts, United States of America. This Conference has been approved for a maximum of 10 CE participation hours. Target Audience: Any dentists, physicians, osteopaths, acupuncturists, chiropractors, nurses, physicians assistants, and nurse practitioners and any other medical or dental professionals whether they can inject or not may attend at full tuition and not as a team member. Course objectives: • How to quickly identify and diagnose facial pain patients in your practice – they are everywhere and have been asking you for treatment! • A step by step comprehensive patient examination and evaluation including a one minute maxillofacial neurological exam, a one minute otic exam, and a thorough head and neck muscle examination • Learn why you should not initially spend a dollar on expensive equipment for facial pain diagnosis and treatment • Learn the two most important tools used to diagnose myofascial pain – one is free and the other one will cost you one penny each! • Learn the real secret of the role of occlusion in orofacial pain – don’t suffer from occlusion confusion any more. • Simple, easy ways to quickly identify if facial pain is coming from the TMJ, neuralgia, ear, eyes, or facial muscles • Trigger point injections – learn how to precisely identify and inject trigger points for instant and long term pain relief  • Understand when to use different chemotherapeutics such as sterile saline, lidocaine, and botulinum toxin for differential diagnosis, pain management, and the best short-term and long-term successful therapeutic outcomes • Learn when to treat and when to refer orofacial pain patients • Common sense diagnosis and treatment planning for TMJ syndrome, headaches and orofacial pain patients • Medical insurance reimbursement for the dental/medical practice for myofascial pain patients with a full list of diagnosis and treatment codes to help you get started immediately • Observe many model patients during the day • One on one comprehensive mentored instruction as you work hands-on your model patient

Detection, Prevention And Management Of Diabetes Complications Course is organized by Harvard Medical School (HMS) and will be held from Aug 04 - 06, 2019 at Fairmont Copley Plaza, Boston, Boston, Massachusetts, United States of America. Who Should Attend: • Physicians, NPs, RNs, PAs, Pharmacists in the fields of:      ○ Internal Medicine      ○ Family Medicine      ○ Geriatric Medicine      ○ Endocrinology • Diabetes Educators • Social Workers Accreditation: Physicians The Harvard Medical School designates this live activity for a maximum of 21.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Risk Management This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 6.25 credits of Risk Management Study. Please check your individual state licensing board requirements before claiming these credits  American Board of Internal Medicine Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.  American Academy of Family Physicians This Live activity, Detection, Prevention and Management of Diabetes Complications, with a beginning date of 08/04/2019, has been reviewed and is acceptable for up to 21.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Why You Should Attend: Increase your skills and knowledge to deliver unparalleled care to your patients. You will leave the course with: • The latest scientific updated on diabetes-related complications care knowledge • Critical insight and teachings from leading authorities and clinical educators • A greater understanding of how to apply the latest tools and tests in your practice Course Description: Diabetes is one of the most common chronic conditions, affecting approximately 425 million individuals worldwide. With rising prevalence and significant delays in the diagnosis of diabetes, it is essential that health care professionals are fluent in the array of care strategies in order to effectively treat patients with the disease, and its complications. Being proactive and engaged on the latest care guidelines promotes the best practices in detection, prevention and management of diabetes-related complications.  This new CME course provides a state-of-the-art update on managing and preventing diabetes-related complications to the spectrum of providers who care for these patients.  Learning activities will center on strategies to prevent and treat microvascular complications including retinopathy, nephropathy, and neuropathy as well as macrovascular complications of cardiovascular disease including coronary artery disease, cerebrovascular disease, and peripheral arterial disease. Innovative Practices For Diabetes-Related Complications This CME course will cover methods on the prevention and management of specific complications related to diabetes including:  Microvascular Complications: • Retinopathy • Nephropathy • Neuropathy Macrovascular Complications of Cardiovascular Disease: • Coronary Artery Disease • Cerebrovascular Disease • Peripheral Arterial Disease Acute Diabetes-Related Complications: • Hypoglycemia • Hyperglycemia • Hyperosmolar Coma • Diabetic Ketoacidosis (DKA) Updated Diabetes Detection Methods: • Hemoglobin A1C Targets • Blood Pressure Targets • Lipid Targets • Eye Examination and Screening for Cardiovascular Disease • Chronic Kidney Disease • Diabetic Foot Ulcers Innovative Treatment Plans for Patients with Complications: • Nutrition Recommendations • Exercise Recommendations • Anti-Diabetes Medication Recommendations Presenters will also discuss the psychosocial aspects of chronic diabetes-related complications and provide specific recommendations for optimal care. This is an excellent opportunity to learn the latest “best practices” and enhance your clinical skills.  Learning Objectives : • Upon completion of this activity, participants will be able to: • Define strategies for identification, prevention and management of diabetes-related microvascular complications • Develop strategies to identify, prevent and manage diabetes-related macrovascular complications • Utilize strategies to reduce the development and progression of diabetes-related complications • Implement practical strategies to detect, prevent and manage common acute diabetes-related complications such as hyper- and hypoglycemia Additional details will be posted as soon as they are available.